nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—hematologic cancer	0.191	1	CbGaD
Zafirlukast—ABCG2—Clofarabine—hematologic cancer	0.0268	0.0492	CbGbCtD
Zafirlukast—CYP1A2—Anagrelide—hematologic cancer	0.016	0.0293	CbGbCtD
Zafirlukast—ABCG2—Daunorubicin—hematologic cancer	0.0157	0.0288	CbGbCtD
Zafirlukast—PTGS1—Bortezomib—hematologic cancer	0.0152	0.0278	CbGbCtD
Zafirlukast—ABCG2—Teniposide—hematologic cancer	0.0137	0.0251	CbGbCtD
Zafirlukast—PTGS1—Thalidomide—hematologic cancer	0.0132	0.0242	CbGbCtD
Zafirlukast—ABCG2—Cladribine—hematologic cancer	0.0131	0.024	CbGbCtD
Zafirlukast—ABCG2—Imatinib—hematologic cancer	0.012	0.0221	CbGbCtD
Zafirlukast—PTGS1—Ifosfamide—hematologic cancer	0.0116	0.0213	CbGbCtD
Zafirlukast—PTGS1—Imatinib—hematologic cancer	0.0111	0.0204	CbGbCtD
Zafirlukast—ABCG2—Nilotinib—hematologic cancer	0.0109	0.0201	CbGbCtD
Zafirlukast—CYP2E1—Thalidomide—hematologic cancer	0.0102	0.0187	CbGbCtD
Zafirlukast—CYP2C9—Bexarotene—hematologic cancer	0.00996	0.0183	CbGbCtD
Zafirlukast—ABCG2—Dasatinib—hematologic cancer	0.00967	0.0177	CbGbCtD
Zafirlukast—ABCG2—Mitoxantrone—hematologic cancer	0.00955	0.0175	CbGbCtD
Zafirlukast—CYP2E1—Dacarbazine—hematologic cancer	0.00878	0.0161	CbGbCtD
Zafirlukast—CYP2C8—Bortezomib—hematologic cancer	0.00876	0.0161	CbGbCtD
Zafirlukast—CYP2D6—Lomustine—hematologic cancer	0.00847	0.0155	CbGbCtD
Zafirlukast—CYP1A2—Carmustine—hematologic cancer	0.00838	0.0154	CbGbCtD
Zafirlukast—CYP2C9—Idarubicin—hematologic cancer	0.00826	0.0151	CbGbCtD
Zafirlukast—CYP2D6—Idarubicin—hematologic cancer	0.00755	0.0138	CbGbCtD
Zafirlukast—ABCG2—Irinotecan—hematologic cancer	0.00752	0.0138	CbGbCtD
Zafirlukast—CYP2C19—Bortezomib—hematologic cancer	0.00735	0.0135	CbGbCtD
Zafirlukast—CYP1A2—Methoxsalen—hematologic cancer	0.00713	0.0131	CbGbCtD
Zafirlukast—CYP2E1—Mitoxantrone—hematologic cancer	0.00681	0.0125	CbGbCtD
Zafirlukast—CYP1A2—Bortezomib—hematologic cancer	0.00678	0.0124	CbGbCtD
Zafirlukast—CYP2C8—Ifosfamide—hematologic cancer	0.00672	0.0123	CbGbCtD
Zafirlukast—ABCG2—Vincristine—hematologic cancer	0.00657	0.0121	CbGbCtD
Zafirlukast—CYP1A2—Daunorubicin—hematologic cancer	0.00648	0.0119	CbGbCtD
Zafirlukast—CYP2D6—Hydroxyurea—hematologic cancer	0.00642	0.0118	CbGbCtD
Zafirlukast—CYP2C19—Thalidomide—hematologic cancer	0.0064	0.0117	CbGbCtD
Zafirlukast—CYP1A2—Alitretinoin—hematologic cancer	0.00635	0.0116	CbGbCtD
Zafirlukast—CYSLTR2—hematopoietic system—hematologic cancer	0.00614	0.206	CbGeAlD
Zafirlukast—ABCG2—Cisplatin—hematologic cancer	0.00613	0.0112	CbGbCtD
Zafirlukast—CYP2C9—Bortezomib—hematologic cancer	0.00611	0.0112	CbGbCtD
Zafirlukast—CYP2C19—Teniposide—hematologic cancer	0.0061	0.0112	CbGbCtD
Zafirlukast—ABCG2—Etoposide—hematologic cancer	0.00602	0.011	CbGbCtD
Zafirlukast—CYP1A2—Thalidomide—hematologic cancer	0.0059	0.0108	CbGbCtD
Zafirlukast—CYP2C8—Nilotinib—hematologic cancer	0.00583	0.0107	CbGbCtD
Zafirlukast—CYP3A4—Bexarotene—hematologic cancer	0.00579	0.0106	CbGbCtD
Zafirlukast—CYP2C19—Ifosfamide—hematologic cancer	0.00563	0.0103	CbGbCtD
Zafirlukast—CYP2D6—Bortezomib—hematologic cancer	0.00558	0.0102	CbGbCtD
Zafirlukast—PTGS1—Etoposide—hematologic cancer	0.00556	0.0102	CbGbCtD
Zafirlukast—CYP3A4—Busulfan—hematologic cancer	0.00539	0.00988	CbGbCtD
Zafirlukast—CYP3A4—Lomustine—hematologic cancer	0.00539	0.00988	CbGbCtD
Zafirlukast—CYP2C19—Imatinib—hematologic cancer	0.00538	0.00987	CbGbCtD
Zafirlukast—CYP2C9—Thalidomide—hematologic cancer	0.00532	0.00976	CbGbCtD
Zafirlukast—CYP1A2—Dacarbazine—hematologic cancer	0.00508	0.00931	CbGbCtD
Zafirlukast—CYP2C9—Teniposide—hematologic cancer	0.00508	0.00931	CbGbCtD
Zafirlukast—CYP1A2—Imatinib—hematologic cancer	0.00497	0.00911	CbGbCtD
Zafirlukast—ABCG2—Dexamethasone—hematologic cancer	0.00495	0.00908	CbGbCtD
Zafirlukast—CYP3A4—Thiotepa—hematologic cancer	0.0048	0.0088	CbGbCtD
Zafirlukast—CYP2C9—Ifosfamide—hematologic cancer	0.00468	0.00859	CbGbCtD
Zafirlukast—CYP2C9—Imatinib—hematologic cancer	0.00447	0.00821	CbGbCtD
Zafirlukast—CYP2E1—Etoposide—hematologic cancer	0.0043	0.00788	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—hematologic cancer	0.00411	0.00754	CbGbCtD
Zafirlukast—CYP2D6—Imatinib—hematologic cancer	0.00409	0.0075	CbGbCtD
Zafirlukast—CYP2C9—Nilotinib—hematologic cancer	0.00407	0.00746	CbGbCtD
Zafirlukast—CYP1A2—Dasatinib—hematologic cancer	0.00399	0.00731	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—hematologic cancer	0.00398	0.0073	CbGbCtD
Zafirlukast—CYP3A4—Methoxsalen—hematologic cancer	0.00373	0.00685	CbGbCtD
Zafirlukast—CYP2D6—Nilotinib—hematologic cancer	0.00372	0.00682	CbGbCtD
Zafirlukast—CYP2D6—Vinorelbine—hematologic cancer	0.00369	0.00676	CbGbCtD
Zafirlukast—CYSLTR2—lung—hematologic cancer	0.00357	0.12	CbGeAlD
Zafirlukast—CYP3A4—Bortezomib—hematologic cancer	0.00355	0.00651	CbGbCtD
Zafirlukast—CYP2C19—Prednisone—hematologic cancer	0.00355	0.0065	CbGbCtD
Zafirlukast—CYP2E1—Dexamethasone—hematologic cancer	0.00353	0.00648	CbGbCtD
Zafirlukast—CYP3A4—Daunorubicin—hematologic cancer	0.0034	0.00623	CbGbCtD
Zafirlukast—CYP2C8—Etoposide—hematologic cancer	0.00321	0.00589	CbGbCtD
Zafirlukast—CYP3A4—Cytarabine—hematologic cancer	0.003	0.00549	CbGbCtD
Zafirlukast—CYP3A4—Teniposide—hematologic cancer	0.00295	0.00541	CbGbCtD
Zafirlukast—CYP3A4—Ifosfamide—hematologic cancer	0.00272	0.00499	CbGbCtD
Zafirlukast—CYP2C8—Dexamethasone—hematologic cancer	0.00264	0.00484	CbGbCtD
Zafirlukast—CYP3A4—Imatinib—hematologic cancer	0.0026	0.00477	CbGbCtD
Zafirlukast—CYP1A2—Etoposide—hematologic cancer	0.00248	0.00456	CbGbCtD
Zafirlukast—CYP3A4—Ruxolitinib—hematologic cancer	0.00245	0.00449	CbGbCtD
Zafirlukast—CYP3A4—Nilotinib—hematologic cancer	0.00236	0.00434	CbGbCtD
Zafirlukast—CYP3A4—Vinorelbine—hematologic cancer	0.00234	0.0043	CbGbCtD
Zafirlukast—CYSLTR1—hematopoietic system—hematologic cancer	0.00231	0.0777	CbGeAlD
Zafirlukast—CYP2C9—Cisplatin—hematologic cancer	0.00228	0.00418	CbGbCtD
Zafirlukast—CYP2D6—Vinblastine—hematologic cancer	0.00227	0.00417	CbGbCtD
Zafirlukast—CYP2C19—Dexamethasone—hematologic cancer	0.00221	0.00406	CbGbCtD
Zafirlukast—CYP3A4—Triamcinolone—hematologic cancer	0.00214	0.00393	CbGbCtD
Zafirlukast—CYP3A4—Dasatinib—hematologic cancer	0.00209	0.00383	CbGbCtD
Zafirlukast—CYP3A4—Mitoxantrone—hematologic cancer	0.00206	0.00379	CbGbCtD
Zafirlukast—CYP2C9—Dexamethasone—hematologic cancer	0.00184	0.00338	CbGbCtD
Zafirlukast—CYP3A4—Betamethasone—hematologic cancer	0.00184	0.00337	CbGbCtD
Zafirlukast—CYP3A4—Prednisolone—hematologic cancer	0.00182	0.00333	CbGbCtD
Zafirlukast—CYP3A4—Prednisone—hematologic cancer	0.00171	0.00314	CbGbCtD
Zafirlukast—CYP2D6—Dexamethasone—hematologic cancer	0.00168	0.00309	CbGbCtD
Zafirlukast—CYP3A4—Irinotecan—hematologic cancer	0.00162	0.00298	CbGbCtD
Zafirlukast—CYSLTR1—blood—hematologic cancer	0.00153	0.0515	CbGeAlD
Zafirlukast—CYSLTR1—bone marrow—hematologic cancer	0.00148	0.0498	CbGeAlD
Zafirlukast—CYP3A4—Vinblastine—hematologic cancer	0.00144	0.00265	CbGbCtD
Zafirlukast—CYP3A4—Vincristine—hematologic cancer	0.00142	0.0026	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—hematologic cancer	0.0014	0.00256	CbGbCtD
Zafirlukast—CYSLTR1—lung—hematologic cancer	0.00134	0.0451	CbGeAlD
Zafirlukast—CYP3A4—Etoposide—hematologic cancer	0.0013	0.00239	CbGbCtD
Zafirlukast—CYP3A4—Dexamethasone—hematologic cancer	0.00107	0.00196	CbGbCtD
Zafirlukast—CYSLTR1—lymph node—hematologic cancer	0.000919	0.0309	CbGeAlD
Zafirlukast—CYP3A4—Doxorubicin—hematologic cancer	0.000888	0.00163	CbGbCtD
Zafirlukast—CYP2C19—hematopoietic system—hematologic cancer	0.000794	0.0267	CbGeAlD
Zafirlukast—CYP2C8—hematopoietic system—hematologic cancer	0.000693	0.0233	CbGeAlD
Zafirlukast—CYP1A2—hematopoietic system—hematologic cancer	0.000649	0.0218	CbGeAlD
Zafirlukast—CYP2C9—hematopoietic system—hematologic cancer	0.000616	0.0207	CbGeAlD
Zafirlukast—CYP2E1—hematopoietic system—hematologic cancer	0.000583	0.0196	CbGeAlD
Zafirlukast—PTGS1—hematopoietic system—hematologic cancer	0.000562	0.0189	CbGeAlD
Zafirlukast—Glyburide—ABCC3—hematologic cancer	0.000559	0.389	CrCbGaD
Zafirlukast—CYP2C19—blood—hematologic cancer	0.000526	0.0177	CbGeAlD
Zafirlukast—CYP3A4—hematopoietic system—hematologic cancer	0.000469	0.0158	CbGeAlD
Zafirlukast—CYP2D6—hematopoietic system—hematologic cancer	0.000462	0.0155	CbGeAlD
Zafirlukast—CYP2C8—blood—hematologic cancer	0.000459	0.0154	CbGeAlD
Zafirlukast—ABCG2—blood—hematologic cancer	0.000446	0.015	CbGeAlD
Zafirlukast—ABCG2—bone marrow—hematologic cancer	0.000432	0.0145	CbGeAlD
Zafirlukast—CYP1A2—blood—hematologic cancer	0.00043	0.0144	CbGeAlD
Zafirlukast—CYP2C9—blood—hematologic cancer	0.000408	0.0137	CbGeAlD
Zafirlukast—ABCG2—lung—hematologic cancer	0.000391	0.0132	CbGeAlD
Zafirlukast—CYP2E1—blood—hematologic cancer	0.000387	0.013	CbGeAlD
Zafirlukast—CYP2C8—testis—hematologic cancer	0.00038	0.0128	CbGeAlD
Zafirlukast—CYP1A2—lung—hematologic cancer	0.000377	0.0127	CbGeAlD
Zafirlukast—Tolvaptan—ABCB1—hematologic cancer	0.000375	0.261	CrCbGaD
Zafirlukast—PTGS1—blood—hematologic cancer	0.000372	0.0125	CbGeAlD
Zafirlukast—ABCG2—testis—hematologic cancer	0.000369	0.0124	CbGeAlD
Zafirlukast—CYP2E1—lung—hematologic cancer	0.000339	0.0114	CbGeAlD
Zafirlukast—PTGS1—lung—hematologic cancer	0.000326	0.011	CbGeAlD
Zafirlukast—CYP2E1—testis—hematologic cancer	0.00032	0.0107	CbGeAlD
Zafirlukast—CYP3A4—blood—hematologic cancer	0.000311	0.0105	CbGeAlD
Zafirlukast—PTGS1—testis—hematologic cancer	0.000308	0.0104	CbGeAlD
Zafirlukast—CYP2D6—blood—hematologic cancer	0.000306	0.0103	CbGeAlD
Zafirlukast—Glyburide—ABCG2—hematologic cancer	0.000272	0.189	CrCbGaD
Zafirlukast—ABCG2—lymph node—hematologic cancer	0.000268	0.009	CbGeAlD
Zafirlukast—CYP2D6—testis—hematologic cancer	0.000253	0.00851	CbGeAlD
Zafirlukast—PTGS1—lymph node—hematologic cancer	0.000223	0.0075	CbGeAlD
Zafirlukast—Glyburide—ALB—hematologic cancer	0.000118	0.0824	CrCbGaD
Zafirlukast—Glyburide—ABCB1—hematologic cancer	0.000113	0.0787	CrCbGaD
Zafirlukast—Dizziness—Vincristine—hematologic cancer	3.95e-05	0.000235	CcSEcCtD
Zafirlukast—Rash—Carmustine—hematologic cancer	3.95e-05	0.000234	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisone—hematologic cancer	3.94e-05	0.000234	CcSEcCtD
Zafirlukast—Dermatitis—Carmustine—hematologic cancer	3.94e-05	0.000234	CcSEcCtD
Zafirlukast—Vomiting—Alitretinoin—hematologic cancer	3.94e-05	0.000234	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisolone—hematologic cancer	3.93e-05	0.000234	CcSEcCtD
Zafirlukast—Headache—Carmustine—hematologic cancer	3.92e-05	0.000233	CcSEcCtD
Zafirlukast—Rash—Alitretinoin—hematologic cancer	3.91e-05	0.000232	CcSEcCtD
Zafirlukast—Dermatitis—Alitretinoin—hematologic cancer	3.91e-05	0.000232	CcSEcCtD
Zafirlukast—Thrombocytopenia—Betamethasone—hematologic cancer	3.9e-05	0.000232	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dexamethasone—hematologic cancer	3.9e-05	0.000232	CcSEcCtD
Zafirlukast—Vomiting—Ifosfamide—hematologic cancer	3.9e-05	0.000231	CcSEcCtD
Zafirlukast—Hypersensitivity—Cisplatin—hematologic cancer	3.89e-05	0.000231	CcSEcCtD
Zafirlukast—Headache—Alitretinoin—hematologic cancer	3.88e-05	0.000231	CcSEcCtD
Zafirlukast—Angioedema—Prednisone—hematologic cancer	3.88e-05	0.000231	CcSEcCtD
Zafirlukast—Diarrhoea—Gemcitabine—hematologic cancer	3.88e-05	0.00023	CcSEcCtD
Zafirlukast—Nausea—Thalidomide—hematologic cancer	3.87e-05	0.00023	CcSEcCtD
Zafirlukast—Dyspepsia—Triamcinolone—hematologic cancer	3.86e-05	0.00023	CcSEcCtD
Zafirlukast—Rash—Ifosfamide—hematologic cancer	3.86e-05	0.000229	CcSEcCtD
Zafirlukast—Dermatitis—Ifosfamide—hematologic cancer	3.86e-05	0.000229	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—hematologic cancer	3.86e-05	0.000229	CcSEcCtD
Zafirlukast—Dizziness—Irinotecan—hematologic cancer	3.85e-05	0.000229	CcSEcCtD
Zafirlukast—Urticaria—Etoposide—hematologic cancer	3.84e-05	0.000228	CcSEcCtD
Zafirlukast—Haemoglobin—Epirubicin—hematologic cancer	3.84e-05	0.000228	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—hematologic cancer	3.84e-05	0.000228	CcSEcCtD
Zafirlukast—Malaise—Prednisone—hematologic cancer	3.83e-05	0.000228	CcSEcCtD
Zafirlukast—Abdominal pain—Etoposide—hematologic cancer	3.83e-05	0.000227	CcSEcCtD
Zafirlukast—Body temperature increased—Etoposide—hematologic cancer	3.83e-05	0.000227	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—hematologic cancer	3.82e-05	0.000227	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—hematologic cancer	3.82e-05	0.000227	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—hematologic cancer	3.8e-05	0.000226	CcSEcCtD
Zafirlukast—Vomiting—Vincristine—hematologic cancer	3.8e-05	0.000226	CcSEcCtD
Zafirlukast—Urticaria—Prednisolone—hematologic cancer	3.79e-05	0.000225	CcSEcCtD
Zafirlukast—Asthenia—Cisplatin—hematologic cancer	3.79e-05	0.000225	CcSEcCtD
Zafirlukast—Fatigue—Triamcinolone—hematologic cancer	3.78e-05	0.000225	CcSEcCtD
Zafirlukast—Rash—Vincristine—hematologic cancer	3.77e-05	0.000224	CcSEcCtD
Zafirlukast—Dermatitis—Vincristine—hematologic cancer	3.76e-05	0.000224	CcSEcCtD
Zafirlukast—Pain—Triamcinolone—hematologic cancer	3.75e-05	0.000223	CcSEcCtD
Zafirlukast—Headache—Vincristine—hematologic cancer	3.74e-05	0.000222	CcSEcCtD
Zafirlukast—Nausea—Carmustine—hematologic cancer	3.72e-05	0.000221	CcSEcCtD
Zafirlukast—Vomiting—Mitoxantrone—hematologic cancer	3.7e-05	0.00022	CcSEcCtD
Zafirlukast—Vomiting—Irinotecan—hematologic cancer	3.7e-05	0.00022	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—hematologic cancer	3.69e-05	0.000219	CcSEcCtD
Zafirlukast—Nausea—Alitretinoin—hematologic cancer	3.68e-05	0.000219	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Zafirlukast—Rash—Irinotecan—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Zafirlukast—Rash—Mitoxantrone—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Zafirlukast—Dermatitis—Mitoxantrone—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Zafirlukast—Dermatitis—Irinotecan—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Zafirlukast—Headache—Irinotecan—hematologic cancer	3.64e-05	0.000216	CcSEcCtD
Zafirlukast—Headache—Mitoxantrone—hematologic cancer	3.64e-05	0.000216	CcSEcCtD
Zafirlukast—Nausea—Ifosfamide—hematologic cancer	3.64e-05	0.000216	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.63e-05	0.000216	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.63e-05	0.000216	CcSEcCtD
Zafirlukast—Arthralgia—Prednisone—hematologic cancer	3.62e-05	0.000215	CcSEcCtD
Zafirlukast—Myalgia—Prednisone—hematologic cancer	3.62e-05	0.000215	CcSEcCtD
Zafirlukast—Feeling abnormal—Triamcinolone—hematologic cancer	3.62e-05	0.000215	CcSEcCtD
Zafirlukast—Diarrhoea—Cisplatin—hematologic cancer	3.61e-05	0.000215	CcSEcCtD
Zafirlukast—Vomiting—Gemcitabine—hematologic cancer	3.6e-05	0.000214	CcSEcCtD
Zafirlukast—Insomnia—Betamethasone—hematologic cancer	3.6e-05	0.000214	CcSEcCtD
Zafirlukast—Insomnia—Dexamethasone—hematologic cancer	3.6e-05	0.000214	CcSEcCtD
Zafirlukast—Discomfort—Prednisone—hematologic cancer	3.57e-05	0.000212	CcSEcCtD
Zafirlukast—Rash—Gemcitabine—hematologic cancer	3.57e-05	0.000212	CcSEcCtD
Zafirlukast—Dermatitis—Gemcitabine—hematologic cancer	3.57e-05	0.000212	CcSEcCtD
Zafirlukast—Hypersensitivity—Etoposide—hematologic cancer	3.57e-05	0.000212	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—hematologic cancer	3.55e-05	0.000211	CcSEcCtD
Zafirlukast—Headache—Gemcitabine—hematologic cancer	3.55e-05	0.000211	CcSEcCtD
Zafirlukast—Nausea—Vincristine—hematologic cancer	3.55e-05	0.000211	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—hematologic cancer	3.53e-05	0.00021	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—hematologic cancer	3.53e-05	0.00021	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisolone—hematologic cancer	3.52e-05	0.000209	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—hematologic cancer	3.52e-05	0.000209	CcSEcCtD
Zafirlukast—Dyspepsia—Dexamethasone—hematologic cancer	3.51e-05	0.000208	CcSEcCtD
Zafirlukast—Dyspepsia—Betamethasone—hematologic cancer	3.51e-05	0.000208	CcSEcCtD
Zafirlukast—Urticaria—Triamcinolone—hematologic cancer	3.49e-05	0.000207	CcSEcCtD
Zafirlukast—Asthenia—Etoposide—hematologic cancer	3.47e-05	0.000206	CcSEcCtD
Zafirlukast—Body temperature increased—Triamcinolone—hematologic cancer	3.47e-05	0.000206	CcSEcCtD
Zafirlukast—Oedema—Prednisone—hematologic cancer	3.47e-05	0.000206	CcSEcCtD
Zafirlukast—Nausea—Irinotecan—hematologic cancer	3.46e-05	0.000205	CcSEcCtD
Zafirlukast—Nausea—Mitoxantrone—hematologic cancer	3.46e-05	0.000205	CcSEcCtD
Zafirlukast—Infection—Prednisone—hematologic cancer	3.45e-05	0.000205	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.44e-05	0.000204	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.44e-05	0.000204	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—hematologic cancer	3.44e-05	0.000204	CcSEcCtD
Zafirlukast—Fatigue—Betamethasone—hematologic cancer	3.43e-05	0.000204	CcSEcCtD
Zafirlukast—Fatigue—Dexamethasone—hematologic cancer	3.43e-05	0.000204	CcSEcCtD
Zafirlukast—Pruritus—Etoposide—hematologic cancer	3.42e-05	0.000203	CcSEcCtD
Zafirlukast—Pain—Dexamethasone—hematologic cancer	3.41e-05	0.000202	CcSEcCtD
Zafirlukast—Pain—Betamethasone—hematologic cancer	3.41e-05	0.000202	CcSEcCtD
Zafirlukast—Nausea—Gemcitabine—hematologic cancer	3.37e-05	0.0002	CcSEcCtD
Zafirlukast—Vomiting—Cisplatin—hematologic cancer	3.36e-05	0.0002	CcSEcCtD
Zafirlukast—Rash—Cisplatin—hematologic cancer	3.33e-05	0.000198	CcSEcCtD
Zafirlukast—Dermatitis—Cisplatin—hematologic cancer	3.33e-05	0.000198	CcSEcCtD
Zafirlukast—Diarrhoea—Etoposide—hematologic cancer	3.31e-05	0.000197	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methotrexate—hematologic cancer	3.3e-05	0.000196	CcSEcCtD
Zafirlukast—Feeling abnormal—Betamethasone—hematologic cancer	3.28e-05	0.000195	CcSEcCtD
Zafirlukast—Feeling abnormal—Dexamethasone—hematologic cancer	3.28e-05	0.000195	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.26e-05	0.000193	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Betamethasone—hematologic cancer	3.26e-05	0.000193	CcSEcCtD
Zafirlukast—Hypersensitivity—Triamcinolone—hematologic cancer	3.23e-05	0.000192	CcSEcCtD
Zafirlukast—Back pain—Epirubicin—hematologic cancer	3.22e-05	0.000191	CcSEcCtD
Zafirlukast—Malaise—Methotrexate—hematologic cancer	3.2e-05	0.00019	CcSEcCtD
Zafirlukast—Dizziness—Etoposide—hematologic cancer	3.2e-05	0.00019	CcSEcCtD
Zafirlukast—Urticaria—Dexamethasone—hematologic cancer	3.16e-05	0.000188	CcSEcCtD
Zafirlukast—Urticaria—Betamethasone—hematologic cancer	3.16e-05	0.000188	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.16e-05	0.000188	CcSEcCtD
Zafirlukast—Dizziness—Prednisolone—hematologic cancer	3.16e-05	0.000187	CcSEcCtD
Zafirlukast—Asthenia—Triamcinolone—hematologic cancer	3.15e-05	0.000187	CcSEcCtD
Zafirlukast—Body temperature increased—Betamethasone—hematologic cancer	3.15e-05	0.000187	CcSEcCtD
Zafirlukast—Body temperature increased—Dexamethasone—hematologic cancer	3.15e-05	0.000187	CcSEcCtD
Zafirlukast—Abdominal pain—Betamethasone—hematologic cancer	3.15e-05	0.000187	CcSEcCtD
Zafirlukast—Abdominal pain—Dexamethasone—hematologic cancer	3.15e-05	0.000187	CcSEcCtD
Zafirlukast—Nausea—Cisplatin—hematologic cancer	3.14e-05	0.000186	CcSEcCtD
Zafirlukast—Insomnia—Prednisone—hematologic cancer	3.14e-05	0.000186	CcSEcCtD
Zafirlukast—Pruritus—Triamcinolone—hematologic cancer	3.11e-05	0.000184	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—hematologic cancer	3.08e-05	0.000183	CcSEcCtD
Zafirlukast—Vomiting—Etoposide—hematologic cancer	3.08e-05	0.000183	CcSEcCtD
Zafirlukast—Dyspepsia—Prednisone—hematologic cancer	3.05e-05	0.000181	CcSEcCtD
Zafirlukast—Rash—Etoposide—hematologic cancer	3.05e-05	0.000181	CcSEcCtD
Zafirlukast—Dermatitis—Etoposide—hematologic cancer	3.05e-05	0.000181	CcSEcCtD
Zafirlukast—Headache—Etoposide—hematologic cancer	3.03e-05	0.00018	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—hematologic cancer	3.02e-05	0.00018	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—hematologic cancer	3.02e-05	0.00018	CcSEcCtD
Zafirlukast—Rash—Prednisolone—hematologic cancer	3.01e-05	0.000179	CcSEcCtD
Zafirlukast—Dermatitis—Prednisolone—hematologic cancer	3.01e-05	0.000179	CcSEcCtD
Zafirlukast—Malaise—Epirubicin—hematologic cancer	3e-05	0.000178	CcSEcCtD
Zafirlukast—Fatigue—Prednisone—hematologic cancer	2.99e-05	0.000178	CcSEcCtD
Zafirlukast—Headache—Prednisolone—hematologic cancer	2.99e-05	0.000178	CcSEcCtD
Zafirlukast—Discomfort—Methotrexate—hematologic cancer	2.99e-05	0.000177	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—hematologic cancer	2.98e-05	0.000177	CcSEcCtD
Zafirlukast—Dizziness—Triamcinolone—hematologic cancer	2.9e-05	0.000172	CcSEcCtD
Zafirlukast—Infection—Methotrexate—hematologic cancer	2.88e-05	0.000171	CcSEcCtD
Zafirlukast—Nausea—Etoposide—hematologic cancer	2.87e-05	0.000171	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisone—hematologic cancer	2.86e-05	0.00017	CcSEcCtD
Zafirlukast—Asthenia—Betamethasone—hematologic cancer	2.86e-05	0.00017	CcSEcCtD
Zafirlukast—Asthenia—Dexamethasone—hematologic cancer	2.86e-05	0.00017	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—hematologic cancer	2.85e-05	0.000169	CcSEcCtD
Zafirlukast—Thrombocytopenia—Methotrexate—hematologic cancer	2.84e-05	0.000169	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Prednisone—hematologic cancer	2.84e-05	0.000168	CcSEcCtD
Zafirlukast—Nausea—Prednisolone—hematologic cancer	2.84e-05	0.000168	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—hematologic cancer	2.83e-05	0.000168	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—hematologic cancer	2.83e-05	0.000168	CcSEcCtD
Zafirlukast—Pruritus—Dexamethasone—hematologic cancer	2.82e-05	0.000167	CcSEcCtD
Zafirlukast—Pruritus—Betamethasone—hematologic cancer	2.82e-05	0.000167	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—hematologic cancer	2.8e-05	0.000166	CcSEcCtD
Zafirlukast—Vomiting—Triamcinolone—hematologic cancer	2.79e-05	0.000166	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—hematologic cancer	2.77e-05	0.000165	CcSEcCtD
Zafirlukast—Rash—Triamcinolone—hematologic cancer	2.77e-05	0.000164	CcSEcCtD
Zafirlukast—Dermatitis—Triamcinolone—hematologic cancer	2.77e-05	0.000164	CcSEcCtD
Zafirlukast—Urticaria—Prednisone—hematologic cancer	2.76e-05	0.000164	CcSEcCtD
Zafirlukast—Headache—Triamcinolone—hematologic cancer	2.75e-05	0.000163	CcSEcCtD
Zafirlukast—Abdominal pain—Prednisone—hematologic cancer	2.74e-05	0.000163	CcSEcCtD
Zafirlukast—Body temperature increased—Prednisone—hematologic cancer	2.74e-05	0.000163	CcSEcCtD
Zafirlukast—Diarrhoea—Betamethasone—hematologic cancer	2.73e-05	0.000162	CcSEcCtD
Zafirlukast—Diarrhoea—Dexamethasone—hematologic cancer	2.73e-05	0.000162	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—hematologic cancer	2.71e-05	0.000161	CcSEcCtD
Zafirlukast—Infection—Epirubicin—hematologic cancer	2.7e-05	0.00016	CcSEcCtD
Zafirlukast—Thrombocytopenia—Epirubicin—hematologic cancer	2.66e-05	0.000158	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.64e-05	0.000157	CcSEcCtD
Zafirlukast—Dizziness—Dexamethasone—hematologic cancer	2.63e-05	0.000156	CcSEcCtD
Zafirlukast—Dizziness—Betamethasone—hematologic cancer	2.63e-05	0.000156	CcSEcCtD
Zafirlukast—Insomnia—Methotrexate—hematologic cancer	2.62e-05	0.000156	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—hematologic cancer	2.62e-05	0.000156	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—hematologic cancer	2.62e-05	0.000156	CcSEcCtD
Zafirlukast—Nausea—Triamcinolone—hematologic cancer	2.61e-05	0.000155	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—hematologic cancer	2.59e-05	0.000154	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisone—hematologic cancer	2.56e-05	0.000152	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—hematologic cancer	2.55e-05	0.000152	CcSEcCtD
Zafirlukast—Vomiting—Betamethasone—hematologic cancer	2.53e-05	0.00015	CcSEcCtD
Zafirlukast—Vomiting—Dexamethasone—hematologic cancer	2.53e-05	0.00015	CcSEcCtD
Zafirlukast—Rash—Betamethasone—hematologic cancer	2.51e-05	0.000149	CcSEcCtD
Zafirlukast—Rash—Dexamethasone—hematologic cancer	2.51e-05	0.000149	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—hematologic cancer	2.51e-05	0.000149	CcSEcCtD
Zafirlukast—Dermatitis—Betamethasone—hematologic cancer	2.51e-05	0.000149	CcSEcCtD
Zafirlukast—Dermatitis—Dexamethasone—hematologic cancer	2.51e-05	0.000149	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.5e-05	0.000149	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—hematologic cancer	2.5e-05	0.000148	CcSEcCtD
Zafirlukast—Headache—Betamethasone—hematologic cancer	2.5e-05	0.000148	CcSEcCtD
Zafirlukast—Headache—Dexamethasone—hematologic cancer	2.5e-05	0.000148	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—hematologic cancer	2.49e-05	0.000148	CcSEcCtD
Zafirlukast—Asthenia—Prednisone—hematologic cancer	2.49e-05	0.000148	CcSEcCtD
Zafirlukast—Pain—Methotrexate—hematologic cancer	2.48e-05	0.000147	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.47e-05	0.000147	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—hematologic cancer	2.46e-05	0.000146	CcSEcCtD
Zafirlukast—Pruritus—Prednisone—hematologic cancer	2.45e-05	0.000146	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—hematologic cancer	2.45e-05	0.000146	CcSEcCtD
Zafirlukast—Feeling abnormal—Methotrexate—hematologic cancer	2.39e-05	0.000142	CcSEcCtD
Zafirlukast—Dyspepsia—Epirubicin—hematologic cancer	2.39e-05	0.000142	CcSEcCtD
Zafirlukast—Diarrhoea—Prednisone—hematologic cancer	2.37e-05	0.000141	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—hematologic cancer	2.37e-05	0.000141	CcSEcCtD
Zafirlukast—Nausea—Dexamethasone—hematologic cancer	2.37e-05	0.000141	CcSEcCtD
Zafirlukast—Nausea—Betamethasone—hematologic cancer	2.37e-05	0.000141	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.34e-05	0.000139	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—hematologic cancer	2.34e-05	0.000139	CcSEcCtD
Zafirlukast—Pain—Epirubicin—hematologic cancer	2.32e-05	0.000138	CcSEcCtD
Zafirlukast—Urticaria—Methotrexate—hematologic cancer	2.3e-05	0.000137	CcSEcCtD
Zafirlukast—Dizziness—Prednisone—hematologic cancer	2.29e-05	0.000136	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—hematologic cancer	2.29e-05	0.000136	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—hematologic cancer	2.29e-05	0.000136	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.29e-05	0.000136	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—hematologic cancer	2.27e-05	0.000135	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—hematologic cancer	2.24e-05	0.000133	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—hematologic cancer	2.22e-05	0.000132	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—hematologic cancer	2.21e-05	0.000131	CcSEcCtD
Zafirlukast—Vomiting—Prednisone—hematologic cancer	2.21e-05	0.000131	CcSEcCtD
Zafirlukast—Rash—Prednisone—hematologic cancer	2.19e-05	0.00013	CcSEcCtD
Zafirlukast—Dermatitis—Prednisone—hematologic cancer	2.19e-05	0.00013	CcSEcCtD
Zafirlukast—Headache—Prednisone—hematologic cancer	2.17e-05	0.000129	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.17e-05	0.000129	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—hematologic cancer	2.16e-05	0.000129	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—hematologic cancer	2.16e-05	0.000128	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—hematologic cancer	2.15e-05	0.000127	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—hematologic cancer	2.14e-05	0.000127	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—hematologic cancer	2.14e-05	0.000127	CcSEcCtD
Zafirlukast—Hypersensitivity—Methotrexate—hematologic cancer	2.14e-05	0.000127	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—hematologic cancer	2.08e-05	0.000124	CcSEcCtD
Zafirlukast—Feeling abnormal—Doxorubicin—hematologic cancer	2.07e-05	0.000123	CcSEcCtD
Zafirlukast—Nausea—Prednisone—hematologic cancer	2.06e-05	0.000122	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.05e-05	0.000122	CcSEcCtD
Zafirlukast—Pruritus—Methotrexate—hematologic cancer	2.05e-05	0.000122	CcSEcCtD
Zafirlukast—Hypersensitivity—Epirubicin—hematologic cancer	2e-05	0.000119	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—hematologic cancer	1.99e-05	0.000118	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—hematologic cancer	1.98e-05	0.000118	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—hematologic cancer	1.98e-05	0.000118	CcSEcCtD
Zafirlukast—Diarrhoea—Methotrexate—hematologic cancer	1.98e-05	0.000118	CcSEcCtD
Zafirlukast—Asthenia—Epirubicin—hematologic cancer	1.95e-05	0.000116	CcSEcCtD
Zafirlukast—Pruritus—Epirubicin—hematologic cancer	1.92e-05	0.000114	CcSEcCtD
Zafirlukast—Dizziness—Methotrexate—hematologic cancer	1.92e-05	0.000114	CcSEcCtD
Zafirlukast—Diarrhoea—Epirubicin—hematologic cancer	1.86e-05	0.00011	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Zafirlukast—Vomiting—Methotrexate—hematologic cancer	1.84e-05	0.000109	CcSEcCtD
Zafirlukast—Rash—Methotrexate—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—hematologic cancer	1.83e-05	0.000108	CcSEcCtD
Zafirlukast—Headache—Methotrexate—hematologic cancer	1.82e-05	0.000108	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—hematologic cancer	1.8e-05	0.000107	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—hematologic cancer	1.79e-05	0.000107	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—hematologic cancer	1.78e-05	0.000105	CcSEcCtD
Zafirlukast—Vomiting—Epirubicin—hematologic cancer	1.72e-05	0.000102	CcSEcCtD
Zafirlukast—Nausea—Methotrexate—hematologic cancer	1.72e-05	0.000102	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—hematologic cancer	1.72e-05	0.000102	CcSEcCtD
Zafirlukast—Rash—Epirubicin—hematologic cancer	1.71e-05	0.000102	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—hematologic cancer	1.71e-05	0.000102	CcSEcCtD
Zafirlukast—Headache—Epirubicin—hematologic cancer	1.7e-05	0.000101	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—hematologic cancer	1.66e-05	9.86e-05	CcSEcCtD
Zafirlukast—Nausea—Epirubicin—hematologic cancer	1.61e-05	9.57e-05	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—hematologic cancer	1.6e-05	9.48e-05	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—hematologic cancer	1.58e-05	9.4e-05	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—hematologic cancer	1.58e-05	9.39e-05	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—hematologic cancer	1.57e-05	9.34e-05	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—hematologic cancer	1.49e-05	8.86e-05	CcSEcCtD
Zafirlukast—CYP2C9—Metabolism—NUP98—hematologic cancer	4.35e-06	6.81e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	4.34e-06	6.8e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.31e-06	6.74e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TXN—hematologic cancer	4.31e-06	6.74e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.31e-06	6.74e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.29e-06	6.71e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.26e-06	6.67e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.26e-06	6.67e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.24e-06	6.63e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NUP214—hematologic cancer	4.23e-06	6.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.23e-06	6.61e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.23e-06	6.61e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.22e-06	6.61e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.22e-06	6.6e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—FHL2—hematologic cancer	4.21e-06	6.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NUP214—hematologic cancer	4.2e-06	6.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SDC1—hematologic cancer	4.19e-06	6.56e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MTHFR—hematologic cancer	4.19e-06	6.55e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.15e-06	6.5e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTR—hematologic cancer	4.15e-06	6.49e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.15e-06	6.49e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AGRN—hematologic cancer	4.13e-06	6.46e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTR—hematologic cancer	4.11e-06	6.43e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.11e-06	6.43e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CA—hematologic cancer	4.09e-06	6.4e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ENO2—hematologic cancer	4.07e-06	6.36e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.05e-06	6.34e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ENO2—hematologic cancer	4.03e-06	6.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4e-06	6.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CD44—hematologic cancer	3.99e-06	6.25e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NQO1—hematologic cancer	3.99e-06	6.25e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—hematologic cancer	3.96e-06	6.19e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.95e-06	6.19e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.94e-06	6.17e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.94e-06	6.17e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.94e-06	6.17e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMMR—hematologic cancer	3.91e-06	6.12e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—IDH2—hematologic cancer	3.91e-06	6.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.91e-06	6.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.91e-06	6.12e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SDC1—hematologic cancer	3.86e-06	6.03e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTP1—hematologic cancer	3.85e-06	6.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.85e-06	6.03e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.84e-06	6.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SDC1—hematologic cancer	3.82e-06	5.98e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRAS—hematologic cancer	3.78e-06	5.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.78e-06	5.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYCS—hematologic cancer	3.78e-06	5.91e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.75e-06	5.88e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NUP98—hematologic cancer	3.72e-06	5.82e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.69e-06	5.77e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.68e-06	5.76e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CG—hematologic cancer	3.66e-06	5.73e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.65e-06	5.71e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCB1—hematologic cancer	3.65e-06	5.71e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—hematologic cancer	3.62e-06	5.67e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.61e-06	5.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.61e-06	5.65e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.6e-06	5.64e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NUP214—hematologic cancer	3.59e-06	5.61e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CA9—hematologic cancer	3.58e-06	5.6e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ACP5—hematologic cancer	3.58e-06	5.6e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CD44—hematologic cancer	3.56e-06	5.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NQO1—hematologic cancer	3.56e-06	5.58e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.55e-06	5.55e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NCOR1—hematologic cancer	3.54e-06	5.54e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTM1—hematologic cancer	3.54e-06	5.54e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.53e-06	5.53e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CG—hematologic cancer	3.52e-06	5.51e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTR—hematologic cancer	3.51e-06	5.5e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.51e-06	5.5e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.49e-06	5.46e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.45e-06	5.39e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ENO2—hematologic cancer	3.45e-06	5.39e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CREBBP—hematologic cancer	3.39e-06	5.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.38e-06	5.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYCS—hematologic cancer	3.37e-06	5.28e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—IDH1—hematologic cancer	3.36e-06	5.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.35e-06	5.24e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.34e-06	5.23e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—hematologic cancer	3.34e-06	5.23e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.33e-06	5.21e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.33e-06	5.2e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.33e-06	5.2e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TXN—hematologic cancer	3.33e-06	5.2e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.29e-06	5.15e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CD44—hematologic cancer	3.28e-06	5.13e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NQO1—hematologic cancer	3.28e-06	5.13e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SDC1—hematologic cancer	3.27e-06	5.11e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CREBBP—hematologic cancer	3.26e-06	5.1e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.25e-06	5.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NQO1—hematologic cancer	3.25e-06	5.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CD44—hematologic cancer	3.25e-06	5.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.22e-06	5.04e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CD—hematologic cancer	3.22e-06	5.04e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.18e-06	4.98e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—hematologic cancer	3.18e-06	4.97e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.15e-06	4.93e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.13e-06	4.9e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.13e-06	4.89e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.12e-06	4.88e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYCS—hematologic cancer	3.1e-06	4.85e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.09e-06	4.84e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.08e-06	4.82e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.08e-06	4.82e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYCS—hematologic cancer	3.07e-06	4.81e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.06e-06	4.79e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.06e-06	4.79e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.06e-06	4.78e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—hematologic cancer	3.05e-06	4.78e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.04e-06	4.76e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.04e-06	4.76e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3R1—hematologic cancer	3.04e-06	4.76e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.02e-06	4.72e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.97e-06	4.65e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.96e-06	4.64e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.95e-06	4.61e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3R1—hematologic cancer	2.92e-06	4.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.88e-06	4.5e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NUP98—hematologic cancer	2.87e-06	4.49e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.81e-06	4.4e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.81e-06	4.39e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.79e-06	4.36e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.79e-06	4.36e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NQO1—hematologic cancer	2.78e-06	4.35e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CD44—hematologic cancer	2.78e-06	4.35e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NUP214—hematologic cancer	2.77e-06	4.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.75e-06	4.3e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.73e-06	4.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.73e-06	4.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.73e-06	4.27e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.72e-06	4.26e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.71e-06	4.24e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTR—hematologic cancer	2.71e-06	4.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.71e-06	4.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.7e-06	4.23e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CB—hematologic cancer	2.7e-06	4.22e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ENO2—hematologic cancer	2.66e-06	4.16e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.63e-06	4.11e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYCS—hematologic cancer	2.63e-06	4.11e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.62e-06	4.1e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.61e-06	4.09e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.59e-06	4.05e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.58e-06	4.04e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.57e-06	4.02e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SDC1—hematologic cancer	2.52e-06	3.94e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.51e-06	3.93e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.51e-06	3.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.49e-06	3.9e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.49e-06	3.9e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.44e-06	3.81e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—hematologic cancer	2.42e-06	3.79e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.41e-06	3.78e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.38e-06	3.73e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.35e-06	3.68e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—hematologic cancer	2.33e-06	3.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.32e-06	3.62e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—EP300—hematologic cancer	2.31e-06	3.62e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.31e-06	3.62e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—hematologic cancer	2.28e-06	3.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.27e-06	3.56e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.24e-06	3.51e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—EP300—hematologic cancer	2.22e-06	3.48e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.22e-06	3.47e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.2e-06	3.44e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.19e-06	3.43e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.18e-06	3.42e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CD44—hematologic cancer	2.14e-06	3.35e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NQO1—hematologic cancer	2.14e-06	3.35e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.13e-06	3.33e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.13e-06	3.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.13e-06	3.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.11e-06	3.3e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.03e-06	3.17e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYCS—hematologic cancer	2.03e-06	3.17e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.01e-06	3.15e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.01e-06	3.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2e-06	3.13e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—hematologic cancer	1.97e-06	3.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.94e-06	3.04e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.89e-06	2.95e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.88e-06	2.94e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.88e-06	2.94e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.87e-06	2.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.85e-06	2.89e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.79e-06	2.8e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.78e-06	2.79e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—hematologic cancer	1.76e-06	2.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.74e-06	2.72e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—hematologic cancer	1.74e-06	2.72e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.73e-06	2.71e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.71e-06	2.68e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.71e-06	2.68e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.69e-06	2.65e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.68e-06	2.64e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—EP300—hematologic cancer	1.66e-06	2.6e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.66e-06	2.59e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.64e-06	2.57e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.64e-06	2.57e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.64e-06	2.57e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.64e-06	2.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.63e-06	2.54e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—hematologic cancer	1.62e-06	2.53e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—hematologic cancer	1.6e-06	2.51e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.58e-06	2.47e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.55e-06	2.43e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.55e-06	2.42e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.54e-06	2.4e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—hematologic cancer	1.5e-06	2.35e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.47e-06	2.29e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.45e-06	2.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—EP300—hematologic cancer	1.43e-06	2.25e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.43e-06	2.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.42e-06	2.22e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—hematologic cancer	1.4e-06	2.19e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.39e-06	2.17e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—hematologic cancer	1.37e-06	2.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—hematologic cancer	1.34e-06	2.1e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—hematologic cancer	1.34e-06	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.31e-06	2.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—EP300—hematologic cancer	1.28e-06	2e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—hematologic cancer	1.24e-06	1.93e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.23e-06	1.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—hematologic cancer	1.22e-06	1.92e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.22e-06	1.91e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.21e-06	1.9e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—EP300—hematologic cancer	1.18e-06	1.84e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—EP300—hematologic cancer	1.17e-06	1.83e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.13e-06	1.77e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.07e-06	1.68e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.06e-06	1.66e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—hematologic cancer	1.06e-06	1.66e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—hematologic cancer	1.05e-06	1.64e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.01e-06	1.58e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—hematologic cancer	1e-06	1.57e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—EP300—hematologic cancer	9.98e-07	1.56e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—hematologic cancer	9.47e-07	1.48e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.35e-07	1.46e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.71e-07	1.36e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—hematologic cancer	8.67e-07	1.36e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.64e-07	1.35e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—hematologic cancer	8.08e-07	1.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—hematologic cancer	7.74e-07	1.21e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—EP300—hematologic cancer	7.7e-07	1.21e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.38e-07	1.16e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—hematologic cancer	7.12e-07	1.11e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—hematologic cancer	7.06e-07	1.1e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—hematologic cancer	6.03e-07	9.44e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.7e-07	8.92e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—hematologic cancer	4.65e-07	7.28e-06	CbGpPWpGaD
